Finch Therapeutics Group, Inc.
FNCH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $25 | $71 | $133 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | -$4 | -$9 |
| Other Curr. Assets | $1 | $1 | $3 | $18 |
| Total Curr. Assets | $11 | $26 | $71 | $143 |
| Property Plant & Equip (Net) | $25 | $27 | $49 | $25 |
| Goodwill | $0 | $0 | $0 | $18 |
| Intangibles | $0 | $0 | $33 | $33 |
| Long-Term Investments | $2 | $2 | $3 | $2 |
| Tax Assets | $12 | $0 | $14 | $7 |
| Other NC Assets | $0 | $0 | -$6 | $7 |
| Total NC Assets | $39 | $30 | $92 | $92 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $50 | $55 | $163 | $225 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $1 | $4 |
| Short-Term Debt | $2 | $3 | $7 | $2 |
| Tax Payable | $0 | $0 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $0 | $6 | $9 |
| Total Curr. Liab. | $3 | $4 | $15 | $15 |
| LT Debt | $26 | $28 | $49 | $10 |
| Deferred Rev, NC | $0 | -$28 | $0 | -$8 |
| Deferred Tax Liab, NC | $12 | $16 | $3 | $10 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $37 | $28 | $53 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $26 | $30 | $38 | $6 |
| Total Liabilities | $41 | $32 | $67 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $225 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$364 | -$350 | -$276 | -$161 |
| AOCI | $0 | $0 | $0 | -$225 |
| Other Equity | $373 | $373 | $371 | $363 |
| Total Equity | $9 | $23 | $96 | $202 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $50 | $55 | $163 | $225 |
| Net Debt | $18 | $7 | -$15 | -$121 |